41 – 60 of 65
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2009
-
Mark
Cost-effectiveness of varenicline compared with nicotine patches for smoking cessation--results from four European countries.
(
- Contribution to journal › Article
-
Mark
Modeling the cost-effectiveness of treatment of rheumatoid arthritis with rituximab using registry data from Southern Sweden
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness analysis of solifenacin flexible dosing in patients with overactive bladder symptoms in four Nordic countries
(
- Contribution to journal › Article
- 2008
-
Mark
The burden of rheumatoid arthritis and access to treatment: outcome and cost-utility of treatments
(
- Contribution to journal › Article
-
Mark
A real-life cost-effectiveness evaluation of budesonide/formoterol maintenance and reliever therapy in asthma
(
- Contribution to journal › Article
- 2007
-
Mark
Cost-effectiveness of tacrolimus ointment vs. standard treatment in patients with moderate and severe atopic dermatitis: a health-economic model simulation based on a patient survey and clinical trial data.
(
- Contribution to journal › Article
-
Mark
Comparison of the cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in the United Kingdom based on two different clinical trials
(
- Contribution to journal › Article
- 2006
-
Mark
Estimating the value of novel interventions for Parkinson's disease: An early decision-making model with application to dopamine cell replacement.
(
- Contribution to journal › Article
-
Mark
At what hip fracture risk is it cost-effective to treat? International intervention thresholds for the treatment of osteoporosis
(
- Contribution to journal › Article
-
Mark
The cost-effectiveness of risedronate in the treatment of osteoporosis: an international perspective
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness analysis of budesonide/formoterol compared with fluticasone in moderate-persistent asthma
(
- Contribution to journal › Article
-
Mark
The impact of decentralised drug-budgets in Sweden - a survey of physicians' attitudes towards costs and cost-effectiveness
(
- Contribution to journal › Article
- 2005
-
Mark
Cost-effectiveness of raloxifene in the UK: an economic evaluation based on the MORE study
(
- Contribution to journal › Article
-
Mark
Intervention thresholds for osteoporosis in men and women: a study based on data from Sweden
(
- Contribution to journal › Article
-
Mark
Intervention thresholds for osteoporosis in the UK
(
- Contribution to journal › Article
- 2004
-
Mark
Using burden of disease/cost-effectiveness as an instrument for district health planning: experiences from Uganda.
(
- Contribution to journal › Article
-
Mark
Cost-effectiveness of risedronate for the treatment of osteoporosis and prevention of fractures in postmenopausal women
(
- Contribution to journal › Article
- 2003
-
Mark
The relative cost-efficiency of arable nitrogen management in Sweden
(
- Contribution to journal › Article
- 2002
-
Mark
Intervention thresholds for osteoporosis
(
- Contribution to journal › Article
- 2001
-
Mark
Adding formoterol to budesonide in moderate asthma--health economic results from the FACET study
(
- Contribution to journal › Article